샘플 요청 목록

 카트 문의
시장보고서
상품코드
1888685

수의 체외수정 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 동물별, 기법별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Veterinary In Vitro Fertilization Market Size, Share & Trends Analysis Report By Product, By Animal, By Technique, By End Use, By Region, And Segment Forecasts, 2025 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수의 체외수정 시장 요약

세계의 수의 체외수정 시장 규모는 2024년에 18억 2,000만 달러로 추정되며, 2033년까지 36억 달러에 달할 것으로 예측됩니다.

2025년부터 2033년까지 8.04%의 CAGR을 기록할 것으로 예상됩니다. 이 시장은 유전적으로 우수한 가축에 대한 수요 증가, 소, 말, 이국적인 동물의 첨단 생식 기술의 보급 확대, 생산성 및 생물 다양성 향상에 기여하는 정부의 동물 번식 및 보호 프로그램 지원책에 힘입어 성장세를 보이고 있습니다.

수의 체외수정(IVF) 산업은 기술 발전과 보다 합리적인 가격의 제품 출시에 힘입어 크게 성장하고 있습니다. 예를 들어, 2024년 9월 인도면역학사(Indian Immunologicals Limited)는 국립낙농개발위원회(NDDB)와 공동으로 국산 IVF 배지 '샤시티(Shashthi)'를 개발했습니다. 이를 통해 수입 배지 대비 배아 1개당 비용을 33% 절감하여 농가 보급을 촉진했습니다. 난자채취(OPU), 체외배아생산(IVEP)과 같은 혁신 기술이 기존 체내 기술을 대체하여 가축의 배아 품질과 유전적 증식을 향상시키고 있습니다. 이러한 발전과 비용 효율적인 IVF 솔루션의 보급이 결합되어 동물병원과 불임 클리닉의 도입이 가속화되면서 생산성 향상과 보조생식술의 광범위한 수용을 촉진하고 있습니다.

또한, IVF의 적용 범위를 가축이나 반려동물에서 야생동물 보호로 확대하는 것이 시장 수요 증가로 이어질 것으로 예상됩니다. 이를 통해 수의생식기술 분야의 투자, 혁신, 다학제적 연구를 촉진하고 종 보존 및 지구적 생물다양성 보전 활동에서 IVF의 역할을 공고히 할 수 있을 것으로 기대됩니다. 예를 들어, 2024년 1월 독일 라이프니츠 동물원 및 야생동물 연구소가 주도하는 BioRescue 컨소시엄의 과학자 팀은 세계 최초로 흰코뿔소의 아종인 남방코뿔소의 배아 이식에 성공하였습니다. 이는 멸종 위기에 처한 북방큰코뿔소 보호에 있어 중요한 이정표가 될 것입니다. 체외수정 기술을 이용해 보존된 정자와 난자로 만들어진 배아는 현재 독일과 이탈리아에 보관되어 있으며, 첫 번째 북부 코뿔소 배아를 케냐의 대리모에게 이식할 계획이 추진되고 있습니다. 첫 번째 임신은 일찍 끝났지만, 이 성과는 코뿔소의 체외수정과 배아 이식이 가능하다는 것을 증명하고 대형 포유류 번식 과학의 획기적인 진전을 이루었습니다.

자주 묻는 질문

  • 수의 체외수정 시장 규모는 어떻게 예측되나요?
  • 수의 체외수정 시장의 성장 요인은 무엇인가요?
  • 수의 체외수정 기술의 최근 발전 사례는 무엇인가요?
  • IVF 기술의 적용 범위는 어떻게 확대되고 있나요?
  • 수의 체외수정 시장의 주요 기업은 어디인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 시장 변수 동향과 범위

  • 시장 계통 전망
    • 상부 시장 전망
    • 관련 시장 전망
  • 시장 역학
  • 가격 분석
  • 시장 분석 툴
    • Porter's Five Forces 분석
    • SWOT 분석에 의한 PESTEL 분석

제4장 수의 체외수정 시장 : 제품별 추정·동향 분석

  • 수의 체외수정 시장 : 제품별 변동 분석
  • 수의 체외수정 시장 : 제품별, 2021년에서 2033년 추정·예측
  • 기기
  • 시약·소모품
  • 서비스

제5장 수의 체외수정 시장 : 동물별 추정·동향 분석

  • 수의 체외수정 시장 : 동물별 변동 분석
  • 수의 체외수정 시장 : 동물별, 2021년에서 2033년 추정·예측
  • 소
  • 돼지
  • 양
  • 염소
  • 말
  • 기타 동물

제6장 수의 체외수정 시장 : 기법별 추정·동향 분석

  • 수의 체외수정 시장 : 기법별 변동 분석
  • 수의 체외수정 시장 : 기법별, 2021년에서 2033년 추정·예측
  • 인공수정
  • 배이식
  • 난자 채취
  • 체외 성숙

제7장 수의 체외수정 시장 : 최종 용도별 추정·동향 분석

  • 수의 체외수정 시장 : 최종 용도별 변동 분석
  • 수의 체외수정 시장 : 최종 용도별, 2021년에서 2033년 추정·예측
    • 수의 불임 치료 클리닉
    • 동물병원
    • 연구소
    • 크라이오 뱅크
    • 기타

제8장 수의 체외수정 시장 : 지역별 추정·동향 분석

  • 지역별 시장 대시보드
  • 지역별 시장 점유율 분석(2024년 및 2033년)
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 태국
    • 한국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 아랍에미리트
    • 사우디아라비아
    • 쿠웨이트
    • 카타르
    • 오만

제9장 경쟁 구도

  • 시장 진입 기업 분류
    • 시장 리더
    • 신흥 기업
  • 시장 점유율/평가 분석(2024년, 히트맵 분석)
  • 기업 개요
    • Zoetis Services LLC
    • Kruuse
    • Hamilton Thorne, Inc.
    • Esco Medical
    • Imy Technologies
    • Minitube
    • Agetech Inc.
    • Orgensen Laboratories
    • Bovine Elite LLC
    • Equine Fertility Centre
    • Veterinary Group
    • Stateline Veterinary Service
  • 기타 주요 기업 리스트
KSM 25.12.29

Veterinary In Vitro Fertilization Market Summary

The global veterinary in vitro fertilization market size was estimated at USD 1.82 billion in 2024 and is projected to reach USD 3.60 billion by 2033, growing at a CAGR of 8.04% from 2025 to 2033. The market is experiencing growth driven by rising demand for genetically superior livestock, increasing adoption of advanced reproductive technologies in cattle, equine, and exotic species, and government initiatives supporting animal breeding and conservation programs, which collectively enhance productivity and biodiversity.

The veterinary in vitro fertilization (IVF) industry is being significantly driven by technological advancements and the launch of more affordable products. For instance, in September 2024, Indian Immunologicals Limited, in collaboration with the National Dairy Development Board (NDDB), developed "Shashthi," an indigenous IVF media, which has reduced the cost per embryo by 33% compared to imported media and has enhanced accessibility for farmers. Innovations such as Ovum Pick Up (OPU) and In Vitro Embryo Production (IVEP) are replacing traditional in vivo techniques, improving embryo quality and genetic multiplication in livestock. These advancements, coupled with the availability of cost-effective IVF solutions, are accelerating adoption across veterinary hospitals and fertility clinics, boosting productivity and fostering widespread acceptance of assisted reproductive technologies.

In addition, expanding the scope of IVF beyond livestock and companion animals into wildlife conservation is expected to boost market demand. It is also expected to drive increased investment, innovation, and cross-disciplinary research in veterinary reproductive technologies, solidifying IVF's role in species preservation and global biodiversity initiatives. For instance, in January 2024, Scientists from the BioRescue consortium, led by Germany's Leibniz Institute for Zoo and Wildlife Research, achieved the world's first successful embryo transfer in southern white rhinos - a major milestone toward saving the nearly extinct northern white rhino. Using IVF, embryos created from preserved sperm and eggs are now stored in Germany and Italy, with plans to implant the first northern white rhino embryo into a surrogate in Kenya. Though the initial pregnancy ended prematurely, the achievement proves that rhino IVF and embryo transfer can work, marking a breakthrough in large-mammal reproduction science.

Global Veterinary In Vitro Fertilization Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary in vitro fertilization market report based on product, animal, technique, end use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Reagents/Consumables
  • Services
  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Bovine
  • Swine
  • Ovine
  • Caprine
  • Equine
  • Other Animals
  • Technique Outlook (Revenue, USD Million, 2021 - 2033)
  • Artificial Insemination
  • Embryo Transfer
  • Ovum Pickup
  • In-Vitro Maturation
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Fertility Clinics
  • Veterinary Hospitals
  • Research Laboratories
  • Cryobanks
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Animal
    • 1.2.3. Technique
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information/Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Model 1: Bottom-Up Analysis
    • 1.7.2. Model 2: Volume-Pricing Analysis
    • 1.7.3. Model 3: Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary/Related Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing demand for meat, dairy, and animal protein products.
      • 3.2.1.2. Rising demand for advanced reproductive technologies in animal breeding
      • 3.2.1.3. Technological advancements in IVF techniques
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of veterinary IVF services
      • 3.2.2.2. Regulatory, ethical and skilled-personnel challenges.
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. Pricing Analysis
  • 3.4. Market Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
    • 3.4.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary In Vitro Fertilization Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Veterinary In Vitro Fertilization Market, By Product Movement Analysis
  • 4.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, by Product, 2021 to 2033 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market Estimates and Forecasts, 2021-2033 (USD Million)
  • 4.5. Reagents/Consumables
    • 4.5.1. Reagents/Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary In Vitro Fertilization Market: Animal Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Veterinary In Vitro Fertilization Market, By Animal Movement Analysis
  • 5.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
  • 5.4. Bovine
    • 5.4.1. Bovine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Swine
    • 5.5.1. Swine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Ovine
    • 5.6.1. Ovine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Caprine
    • 5.7.1. Caprine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Equine
    • 5.8.1. Equine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Others Animals
    • 5.9.1. Others Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary In Vitro Fertilization Market: By Technique Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Veterinary In Vitro Fertilization Market, By Technique Movement Analysis
  • 6.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, By Technique, 2021 to 2033 (USD Million)
  • 6.4. Artificial Insemination
    • 6.4.1. Artificial Insemination Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Embryo Transfer
    • 6.5.1. Embryo Transfer Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Ovum Pickup
    • 6.6.1. Ovum Pickup Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. In-Vitro Maturation
    • 6.7.1. In-Vitro Maturation Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary In Vitro Fertilization Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Veterinary In Vitro Fertilization Market, By End Use Movement Analysis
  • 7.3. Veterinary In Vitro Fertilization Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Fertility Clinics
      • 7.3.1.1. Veterinary Fertility Clinics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Veterinary Hospitals
      • 7.3.2.1. Veterinary Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Research Laboratories
      • 7.3.3.1. Research Laboratories Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Cryobanks
      • 7.3.4.1. Cryobanks Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.5. Others
      • 7.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary In Vitro Fertilization Market: By Regional Estimates & Trend Analysis

  • 8.1. Region Market Dashboard
  • 8.2. Region Market Share Analysis, 2024 & 2033
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Netherlands
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Netherlands Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Sweden
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.4.10. Norway
      • 8.4.10.1. Key Country Dynamics
      • 8.4.10.2. Competitive Scenario
      • 8.4.10.3. Regulatory Framework
      • 8.4.10.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Australia
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. South Korea
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Saudi Arabia
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Qatar
      • 8.7.6.1. Key Country Dynamics
      • 8.7.6.2. Competitive Scenario
      • 8.7.6.3. Regulatory Framework
      • 8.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.7. Oman
      • 8.7.7.1. Key Country Dynamics
      • 8.7.7.2. Competitive Scenario
      • 8.7.7.3. Regulatory Framework
      • 8.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
    • 9.1.1. Market Leaders
    • 9.1.2. Emerging Players
  • 9.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
  • 9.3. Company Profiles
    • 9.3.1. Zoetis Services LLC
      • 9.3.1.1. Participant's Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product/Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Kruuse
      • 9.3.2.1. Participant's Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product/Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Hamilton Thorne, Inc.
      • 9.3.3.1. Participant's Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product/Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Esco Medical
      • 9.3.4.1. Participant's Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product/Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Imy Technologies
      • 9.3.5.1. Participant's Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product/Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Minitube
      • 9.3.6.1. Participant's Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product/Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Agetech Inc.
      • 9.3.7.1. Participant's Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product/Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Orgensen Laboratories
      • 9.3.8.1. Participant's Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Product/Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Bovine Elite LLC
      • 9.3.9.1. Participant's Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Product/Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Equine Fertility Centre
      • 9.3.10.1. Participant's Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Product/Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Veterinary Group
      • 9.3.11.1. Participant's Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Product/Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Stateline Veterinary Service
      • 9.3.12.1. Participant's Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Product/Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
  • 9.4. List of other key players
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제